Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

A new study is set to investigate how artificial intelligence (AI) could significantly improve doctors' decisions regarding prostate cancer treatment. While diagnostic methods for the disease have ...

In cases of clinical equipoise, the highest MMAI score quartile could guide selective treatment intensification among patients with high-risk nonmetastatic prostate cancer. An artificial ...

A new AI test can pick out which men with high-risk prostate cancer that has not spread will require life-extending drug abiraterone. Scientists from The Institute of Cancer Research, London, and ...